Welcome back Rounds Table Listeners!
This week we interview Dr. Donald Arnold, a McMaster University professor and hematologist who is leading the CONCOR-1 trial.
The CONvalescent Plasma for COVID-19 Research Trial (CONCOR-1), is a North American clinical trial designed to evaluate the efficacy and safety of COVID-19 convalescent plasma as a therapy for patients with COVID-19 respiratory illness.
It involves collecting plasma containing neutralizing antibodies from individuals who have recovered from the infection and transfusing it to patients with acute COVID-19 infection.
You can find out more information about the CONCOR-1 trial here:
- CONCOR-1 website: https://concor1.ca
- CONCOR-1 Twitter: https://twitter.com/CONCOR1Trial
- CONCOR-1 Facebook: https://www.facebook.com/concor1trial/
Questions? Comments? Feedback? We’d love to hear from you.